On the estimation of disease prevalence by latent class models for screening studies using two screening tests with categorical disease status verified in test positives only

被引:14
|
作者
Chu, Haitao [1 ,2 ]
Zhou, Yijie [3 ]
Cole, Stephen R. [4 ]
Ibrahim, Joseph G. [2 ]
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27599 USA
[3] Merck & Co Inc, Merck Res Labs, Rahway, NJ 07065 USA
[4] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA
关键词
maximum likelihood; Bayesian inference; diagnostic test; dependence; screening; latent class models; ESTIMATING DIAGNOSTIC-ACCURACY; CAPTURE-RECAPTURE APPROACH; LONGITUDINAL DATA-ANALYSIS; CONDITIONAL DEPENDENCE; PRIOR INFORMATION; GOLD STANDARD; ERROR; SENSITIVITY; AVAILABILITY; SPECIFICITY;
D O I
10.1002/sim.3862
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
To evaluate the probabilities of a disease state, ideally all subjects in a study should be diagnosed by a definitive diagnostic or gold standard test. However, since definitive diagnostic tests are often invasive and expensive, it is generally unethical to apply them to subjects whose screening tests are negative. In this article, we consider latent class models for screening studies with two imperfect binary diagnostic tests and a definitive categorical disease status measured only for those with at least one positive screening test. Specifically, we discuss a conditional-independent and three homogeneous conditional-dependent latent class models and assess the impact of misspecification of the dependence structure on the estimation of disease category probabilities using frequentist and Bayesian approaches. Interestingly, the three homogeneous-dependent models can provide identical goodness-of-fit but substantively different estimates for a given study. However, the parametric form of the assumed dependence structure itself is not 'testable' from the data, and thus the dependence structure modeling considered here can only be viewed as a sensitivity analysis concerning a more complicated non-identifiable model potentially involving a heterogeneous dependence structure. Furthermore, we discuss Bayesian model averaging together with its limitations as an alternative way to partially address this particularly challenging problem. The methods are applied to two cancer screening studies, and simulations are conducted to evaluate the performance of these methods. In summary, further research is needed to reduce the impact of model misspecification on the estimation of disease prevalence in such settings. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:1206 / 1218
页数:13
相关论文
共 21 条
  • [1] A two-stage estimation for screening studies using two diagnostic tests with binary disease status verified in test positives only
    Li, Feng
    Chu, Haitao
    Nie, Lei
    STATISTICAL METHODS IN MEDICAL RESEARCH, 2015, 24 (06) : 635 - 656
  • [2] Prevalence estimation when disease status is verified only among test positives: Applications in HIV screening programs
    Thomas, Emma G.
    Peskoe, Sarah B.
    Spiegelman, Donna
    STATISTICS IN MEDICINE, 2018, 37 (07) : 1101 - 1114
  • [3] A capture-recapture approach for screening using two diagnostic tests with availability of disease status for the test positives only
    Boehning, Dankmar
    Patilea, Valentin
    JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2008, 103 (481) : 212 - 221
  • [4] Comparing the accuracy of screening tests with verification of disease status restricted to test positives
    Wang, Lu
    Zhou, Xiao-Hua
    STATISTICS IN MEDICINE, 2022, 41 (06) : 994 - 1008
  • [5] A Few Remarks on "A Capture-Recapture Approach for Screening Using Two Diagnostic Tests With Availability of Disease Status for the Test Positives Only" by Bohning and Patilea
    Chu, Haitao
    Nie, Lei
    JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 2008, 103 (484) : 1518 - 1519
  • [6] Estimation of disease prevalence, true positive rate, and false positive rate of two screening tests when disease verification is applied on only screen-positives: A hierarchical model using multi-center data
    Stock, Eileen M.
    Stamey, James D.
    Sankaranarayanan, Rengaswamy
    Young, Dean M.
    Muwonge, Richard
    Arbyn, Marc
    CANCER EPIDEMIOLOGY, 2012, 36 (02) : 153 - 160
  • [7] Using Relative Statistics and Approximate Disease Prevalence to Compare Screening Tests
    Samuelson, Frank
    Abbey, Craig
    INTERNATIONAL JOURNAL OF BIOSTATISTICS, 2016, 12 (02):
  • [8] Development and validation of a screening algorithm for Alzheimer's disease using the categorical fluency test
    Chi, Yeon Kyung
    Kang, So Young
    Han, Ji Won
    Jeong, Hyeon
    Park, Jae Young
    Kim, Tae Hui
    Kim, Ki Woong
    Lee, Jung Jae
    Lee, Seok Bum
    Park, Joon Hyuk
    Yoon, Jong Chul
    Kim, Jeong Lan
    Ryu, Seung-Ho
    Jhoo, Jin Hyeong
    Lee, Dong Young
    INTERNATIONAL PSYCHOGERIATRICS, 2013, 25 : S113 - S114
  • [9] A two-stage Bayesian method for estimating accuracy and disease prevalence for two dependent dichotomous screening tests when the status of individuals who are negative on both tests is unverified
    Liu, Jin
    Chen, Feng
    Yu, Hao
    Zeng, Ping
    Liu, Liya
    BMC MEDICAL RESEARCH METHODOLOGY, 2014, 14
  • [10] A two-stage Bayesian method for estimating accuracy and disease prevalence for two dependent dichotomous screening tests when the status of individuals who are negative on both tests is unverified
    Jin Liu
    Feng Chen
    Hao Yu
    Ping Zeng
    Liya Liu
    BMC Medical Research Methodology, 14